Tumor Necrosis Factor-Alpha (+489 G/A) Polymorphism Can Predict the Response to Adalimumab in Chinese Han Patients With Ankylosing Spondylitis

Background: Studies investigating the association between single nucleotide polymorphisms (SNPs) of tumor necrosis factor-alpha (TNFα) and the efficacy of adalimumab (ADA) in ankylosing spondylitis (AS) therapy have reported conflicting results. We aimed to investigate the value of SNP typing of TNF...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hong-Jin, Jiang, Xiao-Min, Shen, Feng-Cai, Peng, Jian-Hua, Wang, Dan-Min, Huang, Shu-Xin, Hou, Zhi-duo, Lin, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465804/
https://www.ncbi.nlm.nih.gov/pubmed/37654943
http://dx.doi.org/10.7759/cureus.42704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465804/
https://www.ncbi.nlm.nih.gov/pubmed/37654943
http://dx.doi.org/10.7759/cureus.42704

Ejemplares similares